Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
PITTSBURGH, Pa., Dec. 3, 2015 (GLOBE NEWSWIRE) -- via PRWEB - ISMETT, a leading Italian transplant hospital managed by UPMC, was recently ranked among the top hospitals in the country based on 30-day...
-
GETTYSBURG, Pa., Dec. 3, 2015 (GLOBE NEWSWIRE) -- Children in the foster care system have very unique needs as a result of high levels of trauma, transiency, psychotropic medication use, and higher...
-
TUCSON, Ariz., Dec. 03, 2015 (GLOBE NEWSWIRE) -- The lengthy and complex Patient Protection and Affordable Care Act (ACA) was not written quickly in 2008 by elected representatives and their...
-
TARRYTOWN, N.Y., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has completed enrollment in its Phase 2b clinical trial of its ultra-orphan...
-
BELGRADE, Mont., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative...
-
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company focused on developing and...
-
LOS ANGELES, Dec. 3, 2015 (GLOBE NEWSWIRE) -- Visceral fat is the most difficult to lose and the most dangerous to have. It quietly accumulates in the belly, hips, thighs, underarms and buttocks,...
-
BOSTON, Dec. 02, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and...
-
MT. LAUREL, N.J., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Former NFL football players suffering from painful musculoskeletal disorders will now have a new therapy treatment opportunity thanks to recently...
-
Lire la version française BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of T/CLorazepam Injection USP 2 mg/mL, a new concentration now...